RAJIV AGGARWAL: Open Payments
NPI 1518146554 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 43 payments from 12 companies in 2025. Trend: 2023 $1,143 · 2024 $922 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $235 |
| AstraZeneca Pharmaceuticals LP | 4 | $192 |
| Lilly USA, LLC | 7 | $183 |
| Amgen Inc. | 11 | $182 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Almatica Pharma LLC | 2 | $53 |
| Paratek Pharmaceuticals, Inc. | 2 | $52 |
| Exact Sciences Corporation | 1 | $31 |
Products named: QULIPTA, OTEZLA, AIRSUPRA, JARDIANCE, CAPLYTA, MOUNJARO, LEQVIO, REXULTI.
Industry payments across VA — which companies pay providers there.
